Review of GLP-1 Receptor Agonists in Psoriasis and Psoriatic Arthritis

Giovanni Ciancio authored a narrative review document evaluating the evidence for Glucagon-like peptide-1 receptor agonists (GLP-1RAs) in treating psoriasis and psoriatic arthritis. The 773.6 KB document, last updated in April 2026, discusses preclinical, clinical, and mechanistic research, including references to specific trials like NCT06588296 and NCT06864026. It is licensed under CC-BY-4.0 and hosted on figshare.

Use Cases

• Literature review on the anti-inflammatory effects of GLP-1RAs based on the described narrative review methodology.
• Identifying research gaps in early psoriatic arthritis treatment based on the conclusion that this area lacks dedicated studies.
• Analyzing the relationship between metabolic parameters and disease activity based on the described results from open-label trials.

Strengths

• Document is 773.6 KB, indicating a substantive text-based review.
• Includes specific references to clinical trials (NCT06588296, NCT06864026).
• License is clearly defined as CC-BY-4.0, permitting reuse with attribution.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset's small size (773.6 KB) indicates it is a single document with limited scope.

Provenance

Source

Giovanni Ciancio

Collection Method

Narrative review of published preclinical, clinical, and mechanistic studies.

Freshness

Last updated 2026-04-28 05:27:58; freshness should be verified.